Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
STAT+: Sionna’s experimental cystic fibrosis pill falls flat in mid-stage trial
Дата публикации: 10-08-2026 12:03:17
A pill from Sionna Therapeutics provided no added benefit when combined with Vertex's cystic fibrosis blockbuster Trikafta, a blow to the biotech.
Основное содержимое страницы с новостью.
Experimental pill proved no better than Vertex’s blockbuster Trikafta alone
Adobe
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77.
Sionna Therapeutics said Monday that its experimental pill for cystic fibrosis did not show any benefit when added onto Vertex Pharmaceuticals’ Trikafta in a Phase 2 trial.
The company will no longer try to advance the drug, called SION-719, as an add-on therapy for CF patients. And it hinted at potential layoffs, saying it will “take actions to preserve capital while evaluating next steps.”
Sionna’s stock fell 90% in pre-market trading Monday morning.
STAT+ Exclusive Story
Already have an account? Log in
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
Схожие новости
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal study | 0 | 5.33 | 10-08-2026 |
| 2 | STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer | 0 | 5.33 | 10-08-2026 |
| 3 | STAT+: In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment | 0 | 7.72 | 10-08-2026 |
| 4 | STAT+: Prime wins Beam arbitration, clearing path to clinic | 0 | 7 | 09-07-2026 |
| 5 | STAT+: Pharmalittle: We’re reading about a Sanofi drug shortage, a Jazz Pharma deal, and more | 0 | 8.4 | 10-08-2026 |
| 6 | STAT+: Skylar Bio kicks off new gene therapy trial for deafness | 0 | 7.72 | 11-08-2026 |
| 7 | STAT+: AstraZeneca, Ionis report major trial failure with heart disease drug | -2 | 7 | 09-07-2026 |
| 8 | STAT+: A shortage of two Sanofi medicines for Pompe disease rattles patients | 0 | 5.18 | 09-08-2026 |
| 9 | Sionna Therapeutics (NASDAQ:SION) Given Hold Rating at Stifel Nicolaus | 0 | 10.32 | 10-08-2026 |
| 10 | STAT+: FDA panel to weigh Grail’s Galleri test | 0 | 10 | 10-08-2026 |
Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 10.39. Источник: www.statnews.com.